PepGen 2022 – Meet the DM Drug Developers

Presented on August 5th, 2022.

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about PepGen.

Speakers include:

• Alayna Tress, MPH, Associate Director of Patient Advocacy
• Michelle Mellion, MD, Senior Vice President & Head of Clinical Development
• Jaya Goyal, PhD, Executive Vice President of Research & Preclinical Development
• Holly Hand, Clinical Operations Consultant
• Jane Larkindale, DPhil, Vice President of Clinical Science

Click here to find all our upcoming Meet the DM Drug Developers dates.